Feedback / Questions
ubidecarenone IV (BPM 31510 IV) - BPGbio
https://www.businesswire.com/news/home/20231003221998/en/BPGbio-Announces-Promising-Readout-from-Phase-2a-Trial-Evaluating-BPM-31510-IV-for-Pancreatic-Cancer
Oct 3, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next